@[email protected] to News • 8 months agoFDA’s review of MDMA for PTSD highlights study bias and safety concernsarstechnica.comexternal-linkmessage-square33fedilinkarrow-up1165arrow-down111cross-posted to: [email protected]
arrow-up1154arrow-down1external-linkFDA’s review of MDMA for PTSD highlights study bias and safety concernsarstechnica.com@[email protected] to News • 8 months agomessage-square33fedilinkcross-posted to: [email protected]
minus-square@Lemming6969link-1•8 months agoIt does not have that potential. This should be downvoted to oblivion.
It does not have that potential. This should be downvoted to oblivion.